Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers
暂无分享，去创建一个
V. Pankratz | F. Couch | T. Rebbeck | A. Spurdle | M. Southey | D. Easton | M. Greene | K. Offit | A. Antoniou | S. Buys | G. Chenevix-Trench | U. Hamann | Xiaoqing Chen | K. Stevens | K. Nathanson | Xianshu Wang | I. Andrulis | A. Jakubowska | J. Simard | S. Neuhausen | A. Godwin | E. Imyanitov | A. Osorio | D. Stoppa-Lyonnet | Z. Fredericksen | C. Singer | C. Szabo | A. Arason | L. Sucheston | M. Beattie | M. Thomassen | S. Healey | M. Piedmonte | T. V. Hansen | M. Montagna | M. Caligo | L. Tihomirova | kConFab | German Cancer | Sweden Swedish Breast Cancer Study | H. Netherlands | CONsorzio Studi ITaliani sui Tumori Ereditari Alla Mammella